Video from ECR 2018: Alexander Radbruch on gadolinium retention

The debate over the safety of gadolinium-based contrast agents for MRI shows no sign of going away, and U.S.-style lawsuits filed against radiologists and vendors in Europe is now a distinct possibility. Dr. Alexander Radbruch, JD, head of neuro-oncologic imaging at the German Cancer Research Center in Heidelberg and University Hospital Essen, is both a lawyer and a radiologist, and he presents his views and ideas on this controversial topic.

Video from ECR 2018: Alexander Radbruch on gadolinium retention VIENNA – The debate over the safety of gadolinium-based contrast agents (GBCAs) for MRI shows no sign of going away, and U.S.-style lawsuits filed against radiologists and vendors in Europe is now a distinct possibility. Dr. Alexander Radbruch, head of neuro-oncologic imaging at the German Cancer Research Center in Heidelberg and University Hospital Essen in Germany, is both a lawyer and a radiologist, and he presents his views and ideas on this controversial topic. Caption: Dr. Alexander Radbruch from Heidelberg and Essen Video produced by Christof. G. Pelz I GRAFIFANT Creation. Grafik. Photo I www.grafifant.at